• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉血栓形成中遗传性活化蛋白C抵抗与因子V基因突变之间的联系。

Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.

作者信息

Zöller B, Dahlbäck B

机构信息

Department of Clinical Chemistry, University of Lund, Malmö General Hospital, Sweden.

出版信息

Lancet. 1994 Jun 18;343(8912):1536-8. doi: 10.1016/s0140-6736(94)92940-8.

DOI:10.1016/s0140-6736(94)92940-8
PMID:7911873
Abstract

Resistance to activated protein C (APC) is a major cause of familial thrombophilia, and can be corrected by an anticoagulant activity expressed by purified factor V. We investigated linkage between APC resistance and the factor V gene in a large kindred with familial thrombophilia. Restriction fragment length polymorphisms in exon 13 of the factor V gene were informative in 14 family members. The 100% linkage between factor V gene polymorphism and APC resistance strongly suggested a factor V gene mutation as a cause of APC resistance. A point mutation changing Arg506 in the APC cleavage site to a Gln was found in APC resistant individuals. These results suggest factor V gene mutation to be the most common genetic cause of thrombophilia.

摘要

对活化蛋白C(APC)的抵抗是家族性血栓形成倾向的主要原因,并且可以通过纯化的因子V所表达的抗凝活性来纠正。我们在一个患有家族性血栓形成倾向的大家系中研究了APC抵抗与因子V基因之间的连锁关系。因子V基因第13外显子中的限制性片段长度多态性在14名家庭成员中具有信息性。因子V基因多态性与APC抵抗之间100%的连锁关系强烈提示因子V基因突变是APC抵抗的原因。在APC抵抗个体中发现了一个点突变,该突变将APC裂解位点的精氨酸506变为谷氨酰胺。这些结果提示因子V基因突变是血栓形成倾向最常见的遗传原因。

相似文献

1
Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.静脉血栓形成中遗传性活化蛋白C抵抗与因子V基因突变之间的联系。
Lancet. 1994 Jun 18;343(8912):1536-8. doi: 10.1016/s0140-6736(94)92940-8.
2
Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.遗传性活化蛋白C抵抗是静脉血栓形成的主要原因,它是由凝血因子V基因的突变引起的。
Haemostasis. 1994 Mar-Apr;24(2):139-51. doi: 10.1159/000217094.
3
Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.在50个具有遗传性活化蛋白C抵抗性的易栓症家族中,有47个家族检测到相同的凝血因子V基因突变。
J Clin Invest. 1994 Dec;94(6):2521-4. doi: 10.1172/JCI117623.
4
Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.对活化蛋白C(APC)的抵抗:凝血因子V的精氨酸506突变与血液透析患者的血管通路血栓形成
Nephrol Dial Transplant. 1996 Apr;11(4):668-72. doi: 10.1093/oxfordjournals.ndt.a027357.
5
Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.特发性静脉血栓栓塞症与凝血因子V第506位精氨酸单点突变的关联。
Lancet. 1994 Jun 18;343(8912):1535-6. doi: 10.1016/s0140-6736(94)92939-4.
6
Arterial and venous thrombosis in two Italian families with the factor V Arg506-->Gln mutation.两个携带凝血因子V Arg506→Gln突变的意大利家族中的动脉和静脉血栓形成。
Eur J Haematol. 1996 Jul;57(1):96-100. doi: 10.1111/j.1600-0609.1996.tb00496.x.
7
Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.因因子V突变导致的活化蛋白C抵抗作为遗传性血栓形成倾向的新病因。
Haematologica. 1995 Jul-Aug;80(4):344-56.
8
Molecular genetics of venous thromboembolism.静脉血栓栓塞症的分子遗传学
Ann Med. 1995 Apr;27(2):187-92. doi: 10.3109/07853899509031957.
9
Venous thrombosis in a replanted finger with underlying factor V Leiden mutation.存在潜在凝血因子V莱顿突变的再植手指静脉血栓形成。
Br J Plast Surg. 1998 Jan;51(1):57-8. doi: 10.1054/bjps.1997.0176.
10
[Point mutation G-->A nucleotide 1691 factor V gene as a cause of developing thrombotic complications in a family with plasma resistance to activated protein C].[凝血因子V基因第1691位核苷酸发生G→A点突变作为血浆对活化蛋白C抵抗的一个家族发生血栓并发症的原因]
Pol Arch Med Wewn. 1996 May;95(5):464-70.

引用本文的文献

1
Genetic factors, risk prediction and AI application of thrombotic diseases.血栓性疾病的遗传因素、风险预测及人工智能应用
Exp Hematol Oncol. 2024 Aug 27;13(1):89. doi: 10.1186/s40164-024-00555-x.
2
Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.活化蛋白 C、蛋白 S 和组织因子途径抑制物协同抑制凝血酶的激活。
Thromb Res. 2023 Oct;230:84-93. doi: 10.1016/j.thromres.2023.08.012. Epub 2023 Aug 23.
3
Testing for Factor V Leiden (FVL) and Prothrombin G20210A Genetic Variants.
检测因子 V 莱顿(FVL)和凝血酶原 G20210A 基因突变。
Methods Mol Biol. 2023;2663:233-251. doi: 10.1007/978-1-0716-3175-1_14.
4
Laboratory Testing for Activated Protein C Resistance (APCR): An Update.活化蛋白 C 抵抗(APCR)的实验室检测:更新。
Methods Mol Biol. 2023;2663:203-210. doi: 10.1007/978-1-0716-3175-1_11.
5
Thrombin spatial distribution determines protein C activation during hemostasis and thrombosis.凝血酶的空间分布决定了止血和血栓形成过程中蛋白 C 的激活。
Blood. 2022 Mar 24;139(12):1892-1902. doi: 10.1182/blood.2021014338.
6
Kallikrein augments the anticoagulant function of the protein C system in thrombin generation.激肽释放酶增强了凝血酶生成中蛋白 C 系统的抗凝功能。
J Thromb Haemost. 2022 Jan;20(1):48-57. doi: 10.1111/jth.15530. Epub 2021 Sep 28.
7
Activated protein C has a regulatory role in factor VIII function.活化蛋白 C 在因子 VIII 功能中具有调节作用。
Blood. 2021 May 6;137(18):2532-2543. doi: 10.1182/blood.2020007562.
8
Novel single nucleotide mutations in exon-10 of human coagulation Factor V gene in patients with pulmonary thromboembolism.肺血栓栓塞症患者凝血因子V基因第10外显子的新型单核苷酸突变
J Cardiovasc Thorac Res. 2020;12(1):10-14. doi: 10.34172/jcvtr.2020.02. Epub 2020 Jan 28.
9
TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.组织因子途径抑制物α(TFPIα)在凝血起始阶段与活化的因子Ⅴ(FVa)和活化的因子Ⅹ(FXa)相互作用,以抑制凝血酶原酶。
Blood Adv. 2017 Dec 26;1(27):2692-2702. doi: 10.1182/bloodadvances.2017011098.
10
Primary Thrombophilia in México XI: Activated Protein C Resistance Phenotypes are Multifactorial.墨西哥原发性血栓形成倾向研究之十一:活化蛋白C抵抗表型是多因素的。
Indian J Hematol Blood Transfus. 2017 Sep;33(3):375-379. doi: 10.1007/s12288-016-0767-7. Epub 2016 Dec 19.